Clinical Trials
28 trialsSHERLOCK
University Health Network, Toronto
GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer
University of Aarhus
ctDNA in Cutaneous Squamous Cell Carcinoma
Massachusetts Eye and Ear Infirmary
Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML
Peking University People's Hospital
GEMINI Breast
Tempus AI
To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)
Peking University People's Hospital
Caris Biorepository Research Protocol
Caris Science, Inc.
EURHOLY
Assistance Publique - Hôpitaux de Paris
Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma
RenJi Hospital
French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
University Hospital, Montpellier
French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)
University Hospital, Montpellier
NIP IT!
University Health Network, Toronto
LumenDx
JaxBio Ltd
BRALLA
Instituto do Cancer do Estado de São Paulo
CR1STAL
Second Xiangya Hospital of Central South University
MRD-LUNG
University Medical Center Groningen
B-STRONGER-I
Personalis Inc.
BELUGA
Munich Leukemia Laboratory
MRD-CONFIRM
Assistance Publique - Hôpitaux de Paris
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
Second Affiliated Hospital, School of Medicine, Zhejiang University
Chemoimmunotherapy Plus Residual Lesion Irradiation for the Treatment of Extensive Stage Small-cell Lung Cancer
Qingdao Central Hospital
MRD
The First Hospital of Jilin University
Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not
First Affiliated Hospital of Zhejiang University
SCAN-B
Lund University
MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC
Jiangsu Cancer Institute & Hospital
ECMRD-001
Hebei Medical University Fourth Hospital
Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence
Peking University People's Hospital
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Peking University People's Hospital